Is it a medicine? Is it a device? It can be both, says EU court
This article was originally published in Scrip
In a ruling that may come as some surprise to those on both sides of the drug/device divide, the Court of Justice of the EU has ruled that a product can be classified as a medicinal product in one member state and as a medical device in another, and thus be subject to different sets of legislation.
You may also be interested in...
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.